Arteriosklerose und Thrombogenese^[*]

 

^* Herrn Prof. A. Hürlimann zum 60. Geburtstag gewidmet.

• LITERATUR

• 1 Rokitanski C. von Handbuch der speziellen pathologischen Anatomie Bd. 1. Braumüller & Seidel; Wien: 1844 538.
• 2 Duguid J. B. Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J. Pathol. 1946; 58: 207.
• 3 Ross R., Glomset J. A. The pathogenesis of atherosclerosis. New Engl. J. Med. 1976; 295: 369.
• 4 Benditt E. P., Benditt J. M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA 1973; 70: 1753.
• 5 Martin G. M., Sprague C. A. Symposium on in vitro studies related to atherogenesis: life histories of hyperplastoid cell Unes from aorta and skin. Exp. Mol. Pathol. 1973; 18: 125.
• 6 Gray M. F., Lawrie T. D. V., Brooke C. J. W. Isolation and identification of chol-esterol-A-oxide and other minor sterols in human serum. Lipids 1971; 6: 836.
• 7 Schaffner T., Taylor K., Bartucci E. J., Fischer-Dzoga K., Beeson J. H., Glagov S., Wissler R. W. Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages. Am. J. Pathol. 1980; 100: 57.
• 8 Gerrity R. G. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 1981; 103: 181.
• 9 Gerrity R. G., Naito H. K., Richardson M., Schwartz C. J. Dietary induced atherogenesis in swine. Am. J. Pathol. 1979; 95: 775.
• 10 Kuhn H., Lengsfeld H., Baumgart-ner H. R. Diet-induced accumulation of vascular cholesterol is localized in macrophages. Ex-perientia 1982; 38: 743.
• 11 Martin B. M., Gimbrone M. A., Unanue E. R., Cotran R. S. Stimulation of non-lymphoid mesenchymal cell proliferation by a macrophage-derived growth factor. J. Immunol. 1981; 126: 1510.
• 12 Glenn K.C., Ross R. Human monocyte-derived growth factor(s) for mesenchymal cells: Activation of secretion by endotoxin and Concanavalin A. Cell 1981; 25: 603.
• 13 Pearson T. A., Solez K., Dillmann J., Heptinstal R. H. Monoclonal characteristics of organising arterial thrombi: Significance in the origin and growth of human atherosclerotic plaques. Lancet 1979; 8106: 7.
• 14 Thorgeirsson G., Robertson A. L. The vascular endothelium - pathobiologic significance. Am. J. Pathol. 1978; 93: 803.
• 15 Stemerman M. B. Vascular intimai components: Precursors of thrombosis. In: Progress in Hemostasis and Thrombosis. Spaet, T. H. (ed.) 2p. 1. Grune & Stratton; New York: 1974
• 16 Mason R. G., Sharp D., Chuang H. Y. K., Mohammad F. The endothelium. Roles in thrombosis and hemostasis. Arch. Pathol. Lab. Med. 1977; 101: 61.
• 17 Hoak J., Fry G., Czervionke R., Smith B., Haycraft A. Endothelial-platelet interaction: The role of prostacyclin. In: The Regulation of Coagulation. Mann/Taylor (eds.), Elsevier North Holland Inc.; 1980: 471
• 18 Wight T. N. Vessel proteoglycans and thrombogenesis. In: Progress in Hemostasis and Thrombosis. Spaet, T. H. (ed.) 5p. 1. Grune & Stratton; New York: 1979
• 19 Jaques L. B. Heparin: An old drug with a new paradigm. Science 1979; 206: 528.
• 20 Becker C. G., Harpel P. C. A₂-Macroglo-bulin on human vascular endothelium. J. Exp. Med. 1976; 144: 1.
• 21 Busch C, Owen W. C. Identification in vitro of an endothelial cell surface cofactor for antithrombin III. J. Clin. Invest. 1982; 69: 726.
• 22 Chan T. K., Chan V. Antithrombin III the major modulator of intravascular coagulation, is synthesized by human endothelial cells. Thrombos. Haemostas. 1981; 46: 504.
• 23 Baumgartner H. R., Muggli R. Adhesion and aggregation: Morphological demonstration and quantitation in vivo and in vitro. In: platelets in biology and pathology. Gordon, J. L. (ed.) Elsevier/North Holland; Biomedical Press: 1976: 23
• 24 Gimbrone M. A. Culture of vascular endothelium. In: Progress in Hemostasis and Thrombosis. Spaet, T. H. (ed.) 3 1 Grune & Stratton; New York: 1976
• 25 Harker L. A., Ross R., Slichter S. J., Scott C. R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J. Clin. Invest. 1976; 58: 731.
• 26 Gaynor E., Bouvier C. A., Spaet T. H. Circulating endothelial cells in endotoxin-treated rabbits. Clin. Res. 1968; 16: 535.
• 27 Hladovec J. Is the antithrombotic activity of "antiplatelet" drugs based on protection of endothelium? Thrombos. Haemostas. 1979; 41: 774.
• 28 Hladovec J., Prerovsky I., Stanek V., Fabian J. Circulating endothelial cells in acute myocardial infarction and angina pectoris. Klin. Wochenschr. 1978; 56: 1033.
• 29 Moncada S., Gryglewski R., Bunting S., Vane J. R. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 1976; 263: 663.
• 30 Moneada S., Vane J. R. The role of prostacyclin in vascular tissue. Federation Proc. 1979; 38: 66.
• 31 Moneada S., Herman A. G., Higgs E. A., Vane J. R. Differential formation of prostacyclin (PGX or PGI₂) by layers of the arterial wall. An explanation for the antithrombotic properties of vascular endothelium. Thromb. Res. 1977; 11: 323.
• 32 Dejana E., Cazenave J. P., Groves H. M., Kinlough-Rathbone R. L., Richardson M., Packham M. A., Mustard J. F. The effect of aspirin inhibition of PGI₂ production on platelet adherence to normal and damaged rabbit aorta. Thromb. Res. 1980; 17: 453.
• 33 Czervionke R. L., Hoak J. C., Fry G. L. Effect of aspirin on thrombin-induced adherence of platelets to cultured cells from the blood vessel wall. J. Clin. Invest. 1979; 62: 847.
• 34 Tschopp T. B., Baumgartner H. R. Platelet adhesion and mural platelet thrombus formation on aortic subendothelium of rats rabbits, and guinea pigs correlate negatively with the vascular PGI₂ production. J. Lab. Clin. Med. 1981; 98: 402.
• 35 Gryglewski R. J., Dembinska-Kiec A., Zmuda A., Gryglewski T. Prostacyclin and thromboxane A₂ biosynthesis capacities of heart arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis 1978; 31: 385.
• 36 Larrue J., Rigaud M., Daret D., Desmond J., Durand J., Bricaud H. Prostacyclin production by cultured smooth muscle cells from atherosclerotic rabbit aorta. Nature 1980; 285: 480.
• 37 Sinzinger H., Feigl W., Silberbauer K., Oppolzer R., Winter M., Auerswald W. Prostacyclin (PGI₂)-generation by different types of human atherosclerotic lesions. Exp. Path. 1980; 18: 175.
• 38 Baumgartner H. R., Spaet T. H. Endothelial replacement in rabbit arteries. Fed. Proc. 1970; 29: 710.
• 39 Clopath P. The effect of acetylsalicylic acid (ASA) on the development of atherosclerotic lesions in miniature swine. Br. J. Exp. Path. 1980; 61: 440.
• 40 Baumgartner H. R., Studer A. Smooth muscle cell proliferation and migration after removal of arterial endothelium in rabbits. In: Atherosclerosis - is it reversible? Schett-ler, G., E. Stange, R. W. Wissler (eds.) Springer, Berlin; Heidelberg, New York: 1978: 12
• 41 Friedman R. J., Stemerman M. B., Wenz B., Moore S., Gauldie J., Gent M., Tiell M. L., Spaet T. H. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. J. Clin. Invest. 1977; 60: 1191.
• 42 Tschopp T. B., Weiss H. J., Baumgartner H. R. Decreased adhesion of platelets to subendothelium in von Willebrand's disease. J. Lab. Clin. Med. 1974; 83: 296
• 43 Fuster V., Bowie E. J. W., Lewis J. C., Fass D. N., Owen C. A., Brown A. L. Resistance to arteriosclerosis in pigs with von Willebrand's disease. J. Clin. Invest. 1978; 61: 722.
• 44 Ross R., Glomset J., Kariya B., Harker L. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Nat Acad. Sci. USA 1974; 71: 1207.
• 45 Moore S., Mustard J., Packham M. A., Kinlough-Rathbone R. L. Thrombosis and endothelial injury in atherogenesis. In: Atherosclerosis IV. Proceedings of the fourth International Symposium on Atherosclerosis. Schettler, G., Y. Goto, Y. Hata, G. Klose (eds.),. Springer Berlin, Heidelberg; New York: 1977
• 46 Turitto V. T., Baumgartner H. R. Platelet interaction with subendothelium in flowing rabbit blood: Effect of blood shear rate. Microvasc. Res. 1979; 17: 38.
• 47 Baumgartner H. R. Pathophysiologische und experimentelle Grundlagen der Throm-bogenese. Schweiz. Med. Wochenschr. 1974; 104: 109.
• 48 Kaplan K. L. Platelet granule proteins: Localization and secretion. In: Platelets in Biology and Pathology - 2. Gordon, J. L. (ed.) Elsevier/North Holland; Biomedical Press: 1981: 77
• 49 Grant J. A., Scrutton M. C. Positive interaction between agonists in the aggregation response of human blood platelets: Interaction between ADP adrenaline and vasopressin. Brit. J. Haematol. 1980; 44: 109.
• 50 O'Brien J. R. A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. Clin. Path. 1964; 17: 275.
• 51 Michal F., Motamed M. Shape change and aggregation of blood platelets: Interaction between the effects of adenosine diphosphate 5-hydroxytryptamine and adrenaline. Br. J. Pharmac. 1976; 56: 209.
• 52 Antoniades H. N., Scher C. D., Stiles C. D. Purification of human platelet-derived growth factor. Proc. Natl. Acad. Sci USA 1979; 76: 1809.
• 53 Heldin C. H., Westermark B., Waste-son A. Platelet-derived growth factor: Purification and partial characterization. Proc. Natl. Acad. Sci. USA 1979; 76: 3722.
• 54 Raines E. W., Ross R. Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J. Biol. Chem. 1982; 257: 5154.
• 55 Ross R., Glomsett J. Atherosclerosis and the arterial smooth muscle cell. Science 1973; 180: 1332.
• 56 Witte L. D., Kaplan K. L., Nossel H. L., Lages B. A., Weiss H. J., Goddman D. S. Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells. Circulation Res. 1978; 42: 402.
• 57 Heldin C. H., Wasteson A., Westermark B. Partial purification of platelet factors stimulating the multiplication of normal human glial cells. Exp. Cell Res. 1977; 109: 429.
• 58 Thorgeirsson G., Robertson A. L. Platelet factors and the human vascular wall. Variations in growth response between endothelial and medial smooth muscle cells. Atherosclerosis 1978; 30: 61.
• 59 Thorgeirsson G., Robertson A. L. Platelet factors and the human vascular wall. Part 2. Such factors are not required for endothelial cell proliferation and migration. Atherosclerosis 1978; 31: 231.
• 60 Grotendorst G. R., Seppä H. E. J., Kleinman H. K., Martin G. R. Attachment of smooth muscle cells to collagen and their migration toward platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 1981; 78: 3669.
• 61 Heldin C. H., Westermark B., Waste-son A. Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. Proc. Natl. Acad. Sci. USA 1981; 78: 3664.
• 62 Bowen-Pope D. F., Ross R. Platelet-derived growth factor. II. Specific binding to cultured cells. J. Biol. Chem. 1982; 257: 5161.
• 63 Habenicht A. J. R., Glomset J. A., Ross R. Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and Swiss 3T3 cells stimulated to divide by platelet-derived growth factor. J. Biol. Chem. 1980; 255: 5134.
• 64 Goldberg I. D., Stemerman M. B., Handin R. I. Vascular permeation of platelet factor 4 after endothelial injury. Science 1980; 209: 611.
• 65 Kaplan K. L., Broeckman M. J., Cher-noff A., Lesznik G. R., Drillings M. Platelet-granule proteins: Studies on release and subcellular localization. Blood 1979; 53: 604.